@article{3636c13180b048429c13b7221c4b97de,
title = "No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML",
keywords = "immunosuppressive agent, natalizumab, immunologic factor, natalizumab, adult, Article, cerebrospinal fluid analysis, clinical outcome, drug induced disease, drug withdrawal, Expanded Disability Status Scale, female, groups by age, human, immunosuppressive treatment, JC virus, major clinical study, male, meta analysis, mortality risk, multiple sclerosis, outcome assessment, overall survival, plasmapheresis, priority journal, progressive multifocal leukoencephalopathy, retrospective study, sex difference, systematic review, disability, Leukoencephalopathy, Progressive Multifocal, Medline, middle aged, mortality, nonparametric test, procedures, statistics and numerical data, treatment outcome, Adult, Disability Evaluation, Female, Humans, Immunologic Factors, Male, Middle Aged, Multiple Sclerosis, Natalizumab, Plasmapheresis, PubMed, Retrospective Studies, Statistics, Nonparametric, Treatment Outcome",
author = "D. Landi and {De Rossi}, N. and S. Zagaglia and C. Scarpazza and L. Prosperini and M. Albanese and F. Buttari and F. Mori and G.A. Marfia and M.P. Sormani and R. Capra and D. Centonze and {Italian PML study group} and Scarpini, {Elio Angelo} and {De Riz}, {Milena Alessandra}",
year = "2017",
doi = "10.1212/WNL.0000000000003740",
language = "English",
volume = "88",
pages = "1144--1152",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",
}